NG00142-Plasma Cell-Free RNA Transcriptomics for AD and Related Dementia

• sa000052 - Plasma Cell-Free RNA Transcriptomics for AD and Related Dementias
  Plasma samples were obtained from the Knight-ADRC and the Movement Disorder Clinic (MDC) at Washington University in Saint Louis repositories. These are deeply phenotyped cohorts, both clinically and molecularly with…

  Learn more

Acknowledgment statement for any data distributed by NIAGADS:

Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer’s Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689), funded by the National Institute on Aging.

Use the study-specific acknowledgement statements below (as applicable):

For investigators using any data from this dataset:

Please cite/reference the use of NIAGADS data by including the accession NG00142.

For investigators using Plasma Cell-Free RNA Transcriptomics for AD and Related Dementias (sa000052) data:

We thank all the participants and their families along with the institutions and all the staff who provided plasma tissue, without whom this study would not have been possible. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, the Neurogenomics and Informatics Center (NGI: https://neurogenomics.wustl.edu/) and the Departments of Neurology and Psychiatry at Washington University School of Medicine.

Cisterna-Garcia A,. et al. Cell-free RNA signatures predict Alzheimer’s disease. iScience. 2023 Nov 23. doi: 10.1016/j.isci.2023.108534. Pubmed Link